These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 16551653)

  • 1. Rapid selection of specific MAP kinase-binders from designed ankyrin repeat protein libraries.
    Amstutz P; Koch H; Binz HK; Deuber SA; Plückthun A
    Protein Eng Des Sel; 2006 May; 19(5):219-29. PubMed ID: 16551653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designed ankyrin repeat proteins (DARPins) as novel isoform-specific intracellular inhibitors of c-Jun N-terminal kinases.
    Parizek P; Kummer L; Rube P; Prinz A; Herberg FW; Plückthun A
    ACS Chem Biol; 2012 Aug; 7(8):1356-66. PubMed ID: 22568706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient selection of DARPins with sub-nanomolar affinities using SRP phage display.
    Steiner D; Forrer P; Plückthun A
    J Mol Biol; 2008 Oct; 382(5):1211-27. PubMed ID: 18706916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From DARPins to LoopDARPins: novel LoopDARPin design allows the selection of low picomolar binders in a single round of ribosome display.
    Schilling J; Schöppe J; Plückthun A
    J Mol Biol; 2014 Feb; 426(3):691-721. PubMed ID: 24513107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-affinity binders selected from designed ankyrin repeat protein libraries.
    Binz HK; Amstutz P; Kohl A; Stumpp MT; Briand C; Forrer P; Grütter MG; Plückthun A
    Nat Biotechnol; 2004 May; 22(5):575-82. PubMed ID: 15097997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct selection of antibodies from complex libraries with the protein fragment complementation assay.
    Koch H; Gräfe N; Schiess R; Plückthun A
    J Mol Biol; 2006 Mar; 357(2):427-41. PubMed ID: 16442560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid selection of high-affinity binders using ribosome display.
    Dreier B; Plückthun A
    Methods Mol Biol; 2012; 805():261-86. PubMed ID: 22094811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Designed ankyrin repeat proteins as anti-idiotypic-binding molecules.
    Vogel M; Keller-Gautschi E; Baumann MJ; Amstutz P; Ruf C; Kricek F; Stadler BM
    Ann N Y Acad Sci; 2007 Aug; 1109():9-18. PubMed ID: 17785285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of mRNA-display-based selections using synthetic peptide and natural protein libraries.
    Huang BC; Liu R
    Biochemistry; 2007 Sep; 46(35):10102-12. PubMed ID: 17685586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A designed ankyrin repeat protein evolved to picomolar affinity to Her2.
    Zahnd C; Wyler E; Schwenk JM; Steiner D; Lawrence MC; McKern NM; Pecorari F; Ward CW; Joos TO; Plückthun A
    J Mol Biol; 2007 Jun; 369(4):1015-28. PubMed ID: 17466328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient tumor targeting with high-affinity designed ankyrin repeat proteins: effects of affinity and molecular size.
    Zahnd C; Kawe M; Stumpp MT; de Pasquale C; Tamaskovic R; Nagy-Davidescu G; Dreier B; Schibli R; Binz HK; Waibel R; Plückthun A
    Cancer Res; 2010 Feb; 70(4):1595-605. PubMed ID: 20124480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribosome display: a technology for selecting and evolving proteins from large libraries.
    Dreier B; Plückthun A
    Methods Mol Biol; 2011; 687():283-306. PubMed ID: 20967617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro selection and characterization of DARPins and Fab fragments for the co-crystallization of membrane proteins: The Na(+)-citrate symporter CitS as an example.
    Huber T; Steiner D; Röthlisberger D; Plückthun A
    J Struct Biol; 2007 Aug; 159(2):206-21. PubMed ID: 17369048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designed ankyrin repeat proteins (DARPins) from research to therapy.
    Tamaskovic R; Simon M; Stefan N; Schwill M; Plückthun A
    Methods Enzymol; 2012; 503():101-34. PubMed ID: 22230567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural determinants for improved stability of designed ankyrin repeat proteins with a redesigned C-capping module.
    Kramer MA; Wetzel SK; Plückthun A; Mittl PR; Grütter MG
    J Mol Biol; 2010 Dec; 404(3):381-91. PubMed ID: 20851127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DARPins: a new generation of protein therapeutics.
    Stumpp MT; Binz HK; Amstutz P
    Drug Discov Today; 2008 Aug; 13(15-16):695-701. PubMed ID: 18621567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DARPins recognizing the tumor-associated antigen EpCAM selected by phage and ribosome display and engineered for multivalency.
    Stefan N; Martin-Killias P; Wyss-Stoeckle S; Honegger A; Zangemeister-Wittke U; Plückthun A
    J Mol Biol; 2011 Nov; 413(4):826-43. PubMed ID: 21963989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ribosome display: selecting and evolving proteins in vitro that specifically bind to a target.
    Zahnd C; Amstutz P; Plückthun A
    Nat Methods; 2007 Mar; 4(3):269-79. PubMed ID: 17327848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of NF-kappaB activation with designed ankyrin-repeat proteins targeting the ubiquitin-binding/oligomerization domain of NEMO.
    Wyler E; Kaminska M; Coïc YM; Baleux F; Véron M; Agou F
    Protein Sci; 2007 Sep; 16(9):2013-22. PubMed ID: 17766391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ribosome display selection of a metal-binding motif from an artificial peptide library.
    Wada A; Sawata SY; Ito Y
    Biotechnol Bioeng; 2008 Dec; 101(5):1102-7. PubMed ID: 18613123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.